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Traditionally the liver biopsy has been used for diagnosis of hepatic disease. This expanded to assessment of extent of fibrosis and inflammation that helps in staging and predicting prognosis in liver disease so that clinical management 3 decisions become easier. While serological tests for fibrosis (Fibro Test) and noninvasive tests (elastography) have been introduced, they have not been uniformly 4, 5 standardized nor are widely available. Histology based on liver biopsy continues 6 to be the most acceptable test.
Worldwide nearly 50% of liver biopsies are still performed without imaging guidance. The use of USG reduces complications and increases the likelihood of specimen adequacy and 3 procedural success. Nearly 50% of liver biopsies in the United States are performed by radiologists and USG is 7 the favored modality.
At national level in a hospital based prospective study the efficacy of 16 and 18-guage needle was assessed on 426 patients of either gender who underwent USG percutaneous liver biopsy for histopathological evaluation of space occupying lesion of liver or diffuse liver disease. It was concluded that USG percutaneous liver biopsy using either 16 or 18-gauge core biopsy needle was safe and effective method to characterize liver pathology with very low rate of 8 complications.
On the global scale, primary liver cancer is a major contributor to both cancer incidence and mortality. It is the sixth most commonly occurring cancer in the world and the third largest cause of cancer mortality. The most common histologic type of primary liver cancer, hepatocellular carcinoma (HCC), is a malignant tumor arising from hepatocytes, the liver's 9 parenchymal cells. Hepatocellular carcinoma differs from most malignancies because it is commonly diagnosed based on imaging features alone, without histologic confirmation. This is because overt hepatocellular carcinoma does not have a portal blood supply; it is supplied solely by abnormal, unpaired hepatic arteries. This results in a characteristic vascular enhancement pattern that can be used to The highest liver cancer incidence rates in the world are reported by registries in Asia and Africa. In contrast to these high rate HCC areas, low rate areas include northern Europe as well as North and 9 South America.
In Pakistan due to the absence of a national cancer registry and screening programs, the data primarily comes from single center experiences or scattered regional registries. Therefore, the prevalence of hepatitis and HCC can only give a rough estimate of the real magnitude of this problem.
Incidence of HCC in Pakistan is on a rise and correlates well with increasing exposure to risk factors for HCC in our population. According to available hospital-based data, age standardized rate for HCC in Pakistan is 7.6 per 100,000 persons per year for males and 
METHODS
Pakhtunkhwa province. The patient selection was based on findings on various image modalities, triphasic liver computed tomography (CT) or dynamic magnetic resonance imaging (MRI), in which percutaneous liver biopsy was indicated. Prior to biopsy the patients were evaluated for the procedure and an informed written consent was taken from them.
The skin site was sterilized and draped to ensure asepsis and the area was anesthetized with xylocaine 2%. Under USG, the deep soft tissues and liver pericapsular areas were also infiltrated with the local anesthetic. We used 18-G Bard Magnum Gun and ensured that the length of biopsy obtained remains between 15 mm to 20 mm to maintain the adequacy for histological diagnosis. The biopsies were routinely processed for histological examination on haematoxylin and eosin (H&E) stain and application of immunohistochemical stains for detecting HCC.
The patients were also assessed serologically by ELISA method for the presence of HCV antibodies and hepatitis B surface antigen (HBsAg).
The data was analyzed in Excel 2016 and SPSS version 19.
A total number of 41 USG percutaneous liver biopsies were performed on patients with liver lesions referred to Kuwait Teaching Hospital, Peshawar. These biopsies were sent to Shaukat Khanum Cancer Hospital & Research
RESULTS
Center Laboratory, Lahore and Agha Khan University Hospital Laboratory, Karachi for immunohistochemical markers and ultimate diagnosis.
The age ranged from 17 to 75 years with a mean of 51.4±11.70 years. Thirtyseven patients were 40 years or older. Males were 26 and females 15 with a ratio 1.6:1.
Out of these 41 liver biopsies 16 (39%) were diagnosed as hepatocellular carcinoma (HCC) on histopathology with 6 of them being HCV positive and 1 showed HBV positivity. Out of 16 cases of HCC 15 (93.7%) had age range from 40-65 years whereas only one (6.3%) was under 40. Among them 13 (81.2%) were males and 3 (18.7%) females with a ratio 3.2:1. On imaging 12 (75%) of them were either diagnosed as HCC or were suspicious of it but all the 7 cases of HCV or HBV were diagnosed as HCC (Table I ).
The next common tumor was metastatic carcinoma with 13 (31.7%) cases diagnosed. Metastatic adenocarcinoma in this group was the most common with 11 (85%) cases followed by metastatic neuroendocrine tumor 2 (15%) cases (Table I) .
Other primary malignant tumors included cholangiocarcinoma 2 cases and one each of neuroendocrine tumor, lymphoproliferative disorder and epithelioid hemangioendothelioma.
Among benign tumors a single case (2.43%) of adenoma was diagnosed.
The next group consisted of 6 (4.63%) benign lesions like cirrhosis 3 (50%) cases out of which 2 were HCV positive, fibrosis 2 (33.3%) cases and an abscess (16.6%). In this group, 03 cases were strongly suggestive of HCC on imaging, but the corresponding biopsy could not reveal malignancy perhaps due to extensive fibrosis and collagenization in cirrhosis leading to nonrepresentative biopsy. In these 03 cases clinicoradiological correlation or a repeat biopsy was recommended. In this study the HCV positivity came out to be 14.6% whereas HBV positivity only 2.43%. Out of HCV positive cases 66.7% developed HCC and 33.3% developed either cirrhosis or extensive fibrosis. The only HBV positive case turned out to be HCC.
TABLE I: DETAILS OF ULTRASOUND GUIDED PERCUTANEOUS LIVER BIOPSIES
All the 16 cases of HCC either showed Hep-Par-1 or arginase positivity which is a novel marker for lesions arising from hepatocytes. All the metastatic tumors were Hep-Par-1 or arginase negative. The individual tumors diagnosed were positive according to their cell type, e.g., cholangiocarcinoma showed positivity for CK7 and CK19, neuroendocrine tumor for CDX-2, lymphoproliferative disorder for CK-30 and CD4 and epithelioid hemangioma for CD34.
The correlation between image and biopsy diagnosis of HCC was statistically significant (p value 0.05) (Table II) . A sensitivity of 75% and specificity of 88% was observed.
Liver disorders which require a percutaneous liver biopsy commonly occurs in older age group with an average of 51.4 years in our setup.
Usually the male population is affected, and the common lesions are HCC, metastatic carcinoma, cirrhosis and fibrosis. HCC, cirrhosis and fibrosis may be related to HCV infection. The present study concludes that image findings are helpful in the initial diagnosis of HCC which shows an increasing tendency to be associated with HCV as compared to HBV with a remarkably declining trend.
